WHO Guideline Development Meeting: Optimal Blood Folate


23 September 2013 - 25 September 2013


Location: World Health Organization headquarters, Geneva, Switzerland

Region: Europe


The guideline development group is to advise WHO on the following:

  • The interpretation of evidence for establishing cut-offs in serum and red blood cells at the individual at public health level, with explicit consideration of the overall balance of risks and benefits.
  • The formulation of final draft recommendations.
  • Determine the strength of these recommendations, considering the balance of evidence for benefits and harms, and taking into account costs, values and preferences.
  • Define implications for research in the areas discussed.
  • Agree on a ‘review by’ date for the discussed guidelines, considering on-going research and controversies.